Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q2 2026 · 10-Q
Revenue$5.64M$5.64M+18.8% vs Q2 2025 Net Income-$797.98K-$797.98KN/M vs Q2 2025 EPS, diluted—
Gross Profit$3,256,922+10.1% Operating Income-$800,784N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$722,500N/M Free Cash Flowderived-$728,248N/M Margins · derivedGross margin57.7%−4.6 pt vs Q2 2025
Operating margin-14.2%−4.0 pt vs Q2 2025
Net margin-14.1%−4.0 pt vs Q2 2025
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end